http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6733752-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32
filingDate 1994-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d52a31de3273fbf2fb2d16e428bd54ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b6e03eda5131fe2d4086fd0806ae1e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76df6acf1432820533776f2faf77f0f4
publicationDate 2004-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6733752-B1
titleOfInvention Prevention of tumors with monoclonal antibodies against neu
abstract Prevention of transformation of a normal cell into a tumour cell in an individual at risk of developing a tumour having tumours which have p185 on their surfaces comprises: (a) identifying the individual and (b) administering to the individual an antibody which specifically binds to p185. Also claimed is a method of preventing transformation of a normal cell into a tumour cell that has p185 on its surface in an individual who has had a tumour that has p185 on its cell surfaces removed or who has had a cancer characterised by tumour cells that have p185 on their surfaces enter remission, comprising (a) identifying the individual and (b) administering to the individual an antibody which specifically binds to p185.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8591897-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8734795-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011020332-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009017023-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009010935-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014060365-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11787873-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009104191-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8597654-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2719706-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020074469-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010119511-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10377825-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006275305-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10584178-B2
priorityDate 1994-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4444744-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5165922-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9400136-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127624528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15764346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21292785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127455638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742317
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID594

Total number of triples: 49.